Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 …

Overview of attention for article published in BMC Cancer, July 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 88 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Complete Pathologic Response to Neoadjuvant Chemoimmunotherapy and Oxaliplatin-Induced Fever Associated With IL-6 Release in a Patient With Locally Advanced Colon Cancer

Cancer Network, 15 Feb 2022

Introduction Colon cancer is the third most common cancer in the United States, with 104,270 new cases in 2021.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.